EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Edaravone on Short‐Term and Long‐Term Motor Recovery After Acute Ischemic Stroke in Patients Who Did Not Receive Thrombolytic or Endovascular Treatment

Mehdi Kazemloo, Fatemeh Shamlouie, Majid Ebrahimi Nejad, Nahid Hosseini Nejad Mir, Danyal Yarahmadi

Acta Neurologica Scandinavica · 2026-01 · 2026 (1)

DOI: 10.1155/ane/5558787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurologica Scandinavica, online erschienen am 10.06.2026. Verfasst von Mehdi Kazemloo und 4 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many patients with acute ischemic stroke (AIS) are ineligible for thrombolysis. Evidence on edaravone in this population is limited.

Methods

This study is a retrospective cohort study on adults with imaging‐confirmed AIS admitted to Shohada‐e‐Ashayer Hospital (March 2022–February 2023) who did not receive thrombolysis. Patients who received intravenous edaravone within the first day of onset plus standard care were compared with standard care alone. Motor strength was assessed with the Medical Research Council (MRC) scale (0–5) at baseline, 1 week, and 3 months. The primary outcome was 3‐month motor function; secondary outcomes included ≥ 2‐point improvement from baseline.

Result

Among 160 patients ( n = 80 edaravone; n = 80 control), baseline characteristics were similar. At 3 months, the intervention group had higher MRC grades and a higher proportion achieving ≥ 2‐grade improvement; 1‐week differences were not significant.

Conclusions

In AIS patients ineligible for thrombolysis, edaravone was associated with better 3‐month motor strength; no significant between‐group differences were observed at 1 week. Prospective randomized trials are warranted.

Zitieren

APA

Kazemloo, M., Shamlouie, F., Nejad, M. E., Mir, N. H. N., & Yarahmadi, D. (2026). Impact of Edaravone on Short‐Term and Long‐Term Motor Recovery After Acute Ischemic Stroke in Patients Who Did Not Receive Thrombolytic or Endovascular Treatment. Acta Neurologica Scandinavica, 2026(1). https://doi.org/10.1155/ane/5558787

Vancouver

Kazemloo M, Shamlouie F, Nejad ME, Mir NHN, Yarahmadi D. Impact of Edaravone on Short‐Term and Long‐Term Motor Recovery After Acute Ischemic Stroke in Patients Who Did Not Receive Thrombolytic or Endovascular Treatment. Acta Neurologica Scandinavica. 2026;2026(1). doi:10.1155/ane/5558787

BibTeX
@article{Kazemloo2026,
  author = {Kazemloo, Mehdi and Shamlouie, Fatemeh and Nejad, Majid Ebrahimi and Mir, Nahid Hosseini Nejad and Yarahmadi, Danyal},
  title = {Impact of Edaravone on Short‐Term and Long‐Term Motor Recovery After Acute Ischemic Stroke in Patients Who Did Not Receive Thrombolytic or Endovascular Treatment},
  journal = {Acta Neurologica Scandinavica},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ane/5558787}
}
Kostenlos starten →